Swedish Pharmaceuticals & Biotech Potentially Undervalued Companies

Sprint Bioscience

Market Cap: SEK 70.5m

A pharmaceutical company, engages in the development of pharmaceutical products in the areas of cancer in Sweden.

Camurus

Market Cap: SEK 36.7b

A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.

Vitrolife

Market Cap: SEK 18.9b

Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.

Magle Chemoswed Holding

Market Cap: SEK 379.9m

Engages in research and development of pharmaceutical and medical device products in Sweden.

Devyser Diagnostics

Market Cap: SEK 1.8b

Engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.

Swedish Orphan Biovitrum

Market Cap: SEK 114.4b

A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.

Saniona

Market Cap: SEK 2.2b

A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of treatments for rare disease patients in Sweden, the United States, Germany, Denmark, and the United Kingdom.

Ascelia Pharma

Market Cap: SEK 356.4m

A biotech company, develops identifies, develops, and commercializes novel drugs to treat orphan oncology treatments in Sweden.

Double Bond Pharmaceutical International

Market Cap: SEK 12.9m

A pharmaceutical company, engages in the development and commercialization of approaches for the treatment of oncological and infectious diseases.

Abera Bioscience

Market Cap: SEK 116.2m

A platform and vaccine development company, research, design, and develops vaccines and immunotherapies based on its proprietary vaccine delivery platform in Sweden and internationally.

Alvotech

Market Cap: SEK 1.6b

Through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide.

BioGaia

Market Cap: SEK 10.2b

A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.

AstraZeneca

Market Cap: SEK 210.4b

A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.

BICO Group

Market Cap: SEK 1.3b

Provides hardware, laboratory automation, and software solutions in North America, Europe, Asia, and internationally.

Guard Therapeutics International

Market Cap: SEK 26.1m

A pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden.

Chosa Oncology

Market Cap: SEK 34.4m

Develops oncology drugs cisplatin for the treatment of cancer.

Inhalation Sciences Sweden

Market Cap: SEK 65.8m

Inhalation Sciences Sweden AB (publ) develops and sells labtech equipment for inhalation research.

Orexo

Market Cap: SEK 928.6m

A specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, the United Kingdom, and internationally.

Nanologica

Market Cap: SEK 95.0m

A nanotechnology company, develops, manufactures, and sells nanoporous silica particles for life science industry in China, India, the United State of America, and internationally.

Bonesupport Holding

Market Cap: SEK 13.1b

An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.

Xbrane Biopharma

Market Cap: SEK 205.1m

A biotechnology company, engages in the development, manufacture, and sale of biosimilars.

Egetis Therapeutics

Market Cap: SEK 2.2b

A pharmaceutical company, focuses on projects in late-stage development for the treatment of serious diseases with unmet medical needs in the orphan drug segment.

Swedencare

Market Cap: SEK 5.5b

Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.

Hansa Biopharma

Market Cap: SEK 2.6b

A biopharmaceutical company, engages in development and commercialization of treatments for patients with rare immunological conditions in Sweden, North America, and rest of Europe.

Biovica International

Market Cap: SEK 150.3m

A biotech company, develops and commercializes novel blood-based biomarker assays that enhance the monitoring and predicting of cancer therapies in the European Union, United States of America, and internationally.

MedCap

Market Cap: SEK 8.0b

A private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, buyout.